Abstract
Vitamin D deficiency is a common problem among elderly nursing home residents. In this Practice Point commentary, I discuss the findings and limitations of a randomized, controlled trial by Chel et al. that evaluated the effect of equivalent oral doses of vitamin D3 given as 600 IU daily, 4,200 IU weekly or 18,000 IU monthly. Regardless of the dosing schedule, oral administration of vitamin D3 was associated with increased levels of serum 25-hydroxyvitamin D and reduced levels of parathyroid hormone in the study cohort. Daily administration of vitamin D3 was found to be more effective than either weekly or monthly administration. The addition of calcium supplementation for a 2-week period did not appreciably augment the effects of vitamin D3 supplementation. Here, I highlight the issues to consider when interpreting studies of vitamin D3 supplementation, its effect on vitamin D status, and the consequences for calcium and bone metabolism.
References
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266–281
Maalouf J et al. (2008) Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J Clin Endocrin Metab 93: 2693–2701
Plotnikoff GA and Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78: 1463–1470
Bischoff-Ferrari HA et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18–28
Chel V et al. (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19: 663–671
Heaney RP et al. (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22: 142–146
Holick MF et al. (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93: 677–681
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Michael F Holick is a consultant, and a member of the speaker's bureau, for the following companies: Amgen, Eli Lilly, Merck, Novartis, Procter and Gamble, and Quest Diagnostics.
Rights and permissions
About this article
Cite this article
Holick, M. Does vitamin D3 dosing schedule influence treatment efficacy in nursing home residents with vitamin D deficiency?. Nat Rev Endocrinol 4, 656–657 (2008). https://doi.org/10.1038/ncpendmet0979
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0979
- Springer Nature Limited